INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 222 filers reported holding INSMED INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $384,597 | +54.1% | 22,557 | +80.6% | 0.00% | -100.0% |
| Q4 2022 | $249,550 | -65.6% | 12,490 | -62.9% | 0.00% | -50.0% |
| Q3 2022 | $725,000 | +187.7% | 33,643 | +354.6% | 0.00% | +100.0% |
| Q1 2021 | $252,000 | -80.5% | 7,400 | -84.3% | 0.00% | -87.5% |
| Q2 2020 | $1,295,000 | +374.4% | 47,000 | +175.1% | 0.01% | +300.0% |
| Q1 2020 | $273,000 | -66.7% | 17,083 | -46.6% | 0.00% | -71.4% |
| Q2 2019 | $820,000 | +114.7% | 32,000 | +143.5% | 0.01% | +75.0% |
| Q1 2019 | $382,000 | – | 13,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |